Intraarterial cis-platinum for patients with inoperable skeletal tumors

Cancer. 1981 Jul 1;48(1):1-4. doi: 10.1002/1097-0142(19810701)48:1<1::aid-cncr2820480102>3.0.co;2-r.

Abstract

Twenty-three patients with inoperable skeletal tumors were treated with intraarterial cis-platinum prior to attempted surgery. The antitumor effect of intraarterial cis-platinum was monitored clinically by radiologic imaging techniques, and whenever possible, evaluated histopathologically by examinatin of surgical or biopsy tumor specimens. Objective responses were noted in 12 patients (52%) and included 2 complete, 7 partial and 3 less-than-partial remissions lasting from 14 to 70 weeks. Limb-saving surgery or hemipelvectomy became subsequently feasible in four and one patients respectively. Preoperative intraarterial cis-platinum is a safe procedure which might be used effectively in combination with other, more conventioal postoperative adjuvant chemotherapy against skeletal tumors.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Neoplasms / drug therapy*
  • Chondrosarcoma / drug therapy
  • Cisplatin / administration & dosage*
  • Clinical Trials as Topic
  • Female
  • Giant Cell Tumors / drug therapy
  • Histiocytoma, Benign Fibrous / drug therapy
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Osteosarcoma / drug therapy
  • Remission, Spontaneous

Substances

  • Cisplatin